G. Ramachandran et al., INCIDENCE OF EXTRAPYRAMIDAL SYNDROMES IN AIDS PATIENTS AND A COMPARISON GROUP OF MEDICALLY ILL INPATIENTS, The Journal of neuropsychiatry and clinical neurosciences, 9(4), 1997, pp. 579-583
The authors retrospectively reviewed the charts of 29 inpatients with
AIDS and 24 medically ill inpatients, all of whom were exposed to neur
oleptics. Results adjusted for age, gender, type and dosage of neurole
ptic, and extrapyramidal prophylaxis indicated that inpatients with AI
DS were 7 times move likely to develop extrapyramidal syndromes (EPS)
from neuroleptics than the comparison group of medically ill inpatient
s. Possible neuroanatomic, neuropathologic, and neurochemical reasons
for the vulnerability of patients with AIDS to EPS are reviewed.